Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
31.21
-0.10 (-0.32%)
At close: Oct 23, 2026, 4:00 PM
31.19
-0.02 (-0.06%)
After-hours: Oct 23, 2026, 4:00 PM EDT
Cogent Biosciences Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, Cogent Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $55.82. The average 1-year stock price forecast is 78.85% higher than the current stock price, while the lowest is $45 (+44.18%) and the highest is $62 (+98.65%).
Price Target: $55.82 (+78.85%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Cogent Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 9 | 9 | 9 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 13 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Buy Maintains $60 | Buy | Maintains | $60 | +92.25% | Oct 14, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $52 | Buy | Maintains | $52 | +66.61% | Oct 6, 2026 |
| Wedbush | Wedbush | Buy Maintains $55 | Buy | Maintains | $55 | +76.23% | Sep 16, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $55 | Buy | Maintains | $55 | +76.23% | Sep 15, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $55 | Buy | Reiterates | $55 | +76.23% | Sep 15, 2026 |
Financial Forecast
Revenue This Year
5.99M
Revenue Next Year
283.70M
from 5.99M
Increased by 4,637.35%
EPS This Year
-2.21
from -2.11
EPS Next Year
-1.18
from -2.21
EPS and Forward PE are based on non-GAAP adjusted numbers.